Cargando…
Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment
BACKGROUND: Patients with multiple sclerosis (MS) demonstrate higher seroprevalence of Epstein-Barr virus (EBV) and increased anti-EBV IgG levels in serum compared with healthy controls. Intrathecal antibody production to measles virus (MeV) is a common finding in patients with MS. OBJECTIVE: To mea...
Autores principales: | Persson Berg, Linn, Eriksson, Marcus, Longhi, Sonia, Kockum, Ingrid, Warnke, Clemens, Thomsson, Elisabeth, Bäckström, Malin, Olsson, Tomas, Fogdell-Hahn, Anna, Bergström, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335035/ https://www.ncbi.nlm.nih.gov/pubmed/35978722 http://dx.doi.org/10.1136/bmjno-2022-000271 |
Ejemplares similares
-
Changes to anti-JCV antibody levels in a Swedish national MS cohort
por: Warnke, Clemens, et al.
Publicado: (2013) -
Smoking and Epstein–Barr virus infection in multiple sclerosis development
por: Hedström, Anna Karin, et al.
Publicado: (2020) -
Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study
por: Manouchehrinia, Ali, et al.
Publicado: (2023) -
Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis
por: Biström, M., et al.
Publicado: (2020) -
Epstein Barr virus infection and immune defense related to HLA‐DR15: consequences for multiple sclerosis
por: Olsson, Tomas
Publicado: (2020)